vs

Side-by-side financial comparison of Quest Diagnostics (DGX) and Venture Global, Inc. (VG). Click either name above to swap in a different company.

Venture Global, Inc. is the larger business by last-quarter revenue ($4.4B vs $2.9B, roughly 1.5× Quest Diagnostics). Venture Global, Inc. runs the higher net margin — 26.8% vs 9.7%, a 17.1% gap on every dollar of revenue. On growth, Venture Global, Inc. posted the faster year-over-year revenue change (191.7% vs 9.2%). Over the past eight quarters, Venture Global, Inc.'s revenue compounded faster (77.3% CAGR vs 9.9%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

S&P Global Inc. is an American publicly traded corporation headquartered in Manhattan, New York. Its primary areas of business are financial information, analytics, and energy and commodities intelligence. It is the parent company of S&P Global Ratings, S&P Global Energy, S&P Global Market Intelligence, S&P Global Mobility, and the Indian credit rating agency CRISIL. It is also the majority owner of the S&P Dow Jones Indices joint venture. "S&P" is a shortening of "Standard and Poor's".

DGX vs VG — Head-to-Head

Bigger by revenue
VG
VG
1.5× larger
VG
$4.4B
$2.9B
DGX
Growing faster (revenue YoY)
VG
VG
+182.5% gap
VG
191.7%
9.2%
DGX
Higher net margin
VG
VG
17.1% more per $
VG
26.8%
9.7%
DGX
Faster 2-yr revenue CAGR
VG
VG
Annualised
VG
77.3%
9.9%
DGX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DGX
DGX
VG
VG
Revenue
$2.9B
$4.4B
Net Profit
$281.0M
$1.2B
Gross Margin
Operating Margin
15.4%
38.7%
Net Margin
9.7%
26.8%
Revenue YoY
9.2%
191.7%
Net Profit YoY
12.0%
20.3%
EPS (diluted)
$2.24
$0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DGX
DGX
VG
VG
Q1 26
$2.9B
Q4 25
$2.8B
$4.4B
Q3 25
$2.8B
$3.3B
Q2 25
$2.8B
$3.1B
Q1 25
$2.7B
$2.9B
Q4 24
$2.6B
$1.5B
Q3 24
$2.5B
$926.0M
Q2 24
$2.4B
$1.1B
Net Profit
DGX
DGX
VG
VG
Q1 26
$281.0M
Q4 25
$245.0M
$1.2B
Q3 25
$245.0M
$550.0M
Q2 25
$282.0M
$475.0M
Q1 25
$220.0M
$517.0M
Q4 24
$222.0M
$990.0M
Q3 24
$226.0M
$-294.0M
Q2 24
$229.0M
$352.0M
Gross Margin
DGX
DGX
VG
VG
Q1 26
Q4 25
32.4%
Q3 25
33.7%
Q2 25
34.2%
Q1 25
32.5%
Q4 24
32.7%
Q3 24
32.6%
Q2 24
33.5%
Operating Margin
DGX
DGX
VG
VG
Q1 26
15.4%
Q4 25
13.8%
38.7%
Q3 25
13.7%
39.7%
Q2 25
15.9%
33.5%
Q1 25
13.0%
37.3%
Q4 24
13.8%
39.0%
Q3 24
13.3%
20.4%
Q2 24
14.8%
32.8%
Net Margin
DGX
DGX
VG
VG
Q1 26
9.7%
Q4 25
8.7%
26.8%
Q3 25
8.7%
16.5%
Q2 25
10.2%
15.3%
Q1 25
8.3%
17.9%
Q4 24
8.5%
65.0%
Q3 24
9.1%
-31.7%
Q2 24
9.6%
31.8%
EPS (diluted)
DGX
DGX
VG
VG
Q1 26
$2.24
Q4 25
$2.18
$0.41
Q3 25
$2.16
$0.16
Q2 25
$2.47
$0.14
Q1 25
$1.94
$0.15
Q4 24
$1.95
$0.35
Q3 24
$1.99
$-0.15
Q2 24
$2.03
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DGX
DGX
VG
VG
Cash + ST InvestmentsLiquidity on hand
$393.0M
$2.4B
Total DebtLower is stronger
$5.7B
$34.2B
Stockholders' EquityBook value
$7.7B
$6.7B
Total Assets
$16.7B
$53.4B
Debt / EquityLower = less leverage
0.74×
5.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DGX
DGX
VG
VG
Q1 26
$393.0M
Q4 25
$420.0M
$2.4B
Q3 25
$432.0M
$1.9B
Q2 25
$319.0M
$2.2B
Q1 25
$188.0M
$3.6B
Q4 24
$549.0M
$3.6B
Q3 24
$764.0M
Q2 24
$271.0M
Total Debt
DGX
DGX
VG
VG
Q1 26
$5.7B
Q4 25
$5.2B
$34.2B
Q3 25
$5.2B
$32.6B
Q2 25
$5.2B
$30.0B
Q1 25
$5.9B
$29.3B
Q4 24
$5.6B
$29.3B
Q3 24
$5.6B
Q2 24
$3.8B
Stockholders' Equity
DGX
DGX
VG
VG
Q1 26
$7.7B
Q4 25
$7.2B
$6.7B
Q3 25
$7.3B
$5.7B
Q2 25
$7.2B
$5.3B
Q1 25
$6.9B
$4.9B
Q4 24
$6.8B
$2.9B
Q3 24
$6.8B
Q2 24
$6.6B
Total Assets
DGX
DGX
VG
VG
Q1 26
$16.7B
Q4 25
$16.2B
$53.4B
Q3 25
$16.2B
$50.1B
Q2 25
$16.0B
$46.5B
Q1 25
$15.8B
$45.1B
Q4 24
$16.2B
$43.5B
Q3 24
$16.1B
Q2 24
$13.9B
Debt / Equity
DGX
DGX
VG
VG
Q1 26
0.74×
Q4 25
0.72×
5.07×
Q3 25
0.71×
5.73×
Q2 25
0.72×
5.69×
Q1 25
0.85×
6.01×
Q4 24
0.83×
10.11×
Q3 24
0.83×
Q2 24
0.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DGX
DGX
VG
VG
Operating Cash FlowLast quarter
$278.0M
$2.1B
Free Cash FlowOCF − Capex
$-1.5B
FCF MarginFCF / Revenue
-34.1%
Capex IntensityCapex / Revenue
3.9%
81.6%
Cash ConversionOCF / Net Profit
0.99×
1.77×
TTM Free Cash FlowTrailing 4 quarters
$-6.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DGX
DGX
VG
VG
Q1 26
$278.0M
Q4 25
$465.0M
$2.1B
Q3 25
$563.0M
$1.9B
Q2 25
$544.0M
$1.5B
Q1 25
$314.0M
$1.1B
Q4 24
$464.0M
Q3 24
$356.0M
Q2 24
$360.0M
Free Cash Flow
DGX
DGX
VG
VG
Q1 26
Q4 25
$307.0M
$-1.5B
Q3 25
$419.0M
$-1.4B
Q2 25
$436.0M
$-1.5B
Q1 25
$197.0M
$-2.4B
Q4 24
$341.0M
Q3 24
$250.0M
Q2 24
$268.0M
FCF Margin
DGX
DGX
VG
VG
Q1 26
Q4 25
10.9%
-34.1%
Q3 25
14.9%
-42.4%
Q2 25
15.8%
-49.1%
Q1 25
7.4%
-81.3%
Q4 24
13.0%
Q3 24
10.0%
Q2 24
11.2%
Capex Intensity
DGX
DGX
VG
VG
Q1 26
3.9%
Q4 25
5.6%
81.6%
Q3 25
5.1%
98.9%
Q2 25
3.9%
96.1%
Q1 25
4.4%
119.8%
Q4 24
4.7%
Q3 24
4.3%
Q2 24
3.8%
Cash Conversion
DGX
DGX
VG
VG
Q1 26
0.99×
Q4 25
1.90×
1.77×
Q3 25
2.30×
3.42×
Q2 25
1.93×
3.07×
Q1 25
1.43×
2.15×
Q4 24
2.09×
Q3 24
1.58×
Q2 24
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DGX
DGX

Segment breakdown not available.

VG
VG

Plaquemines Project Segment$3.4B76%
Calcasieu Project Segment$841.0M19%
Other$208.0M5%

Related Comparisons